an inflation-adjusted billing-code level ASP for such period. (5) Submission of data A rebate agreement under this subsection shall require a manufacturer of an applicable part B drug to submit to the Secretary at such time, and in such manner, as the Secretary may specify such data as the Secretary determines is necessary in order to carry out this subsection. (6) Length of agreement The provisions of paragraph (4) of section 1927(b) (other than clauses (iv) and (v) of subparagraph (B)) shall apply to rebate agreements under this subsection in the same manner as such paragraph applies to a rebate agreement under such section. (7) Other terms and conditions The Secretary shall establish other terms and conditions of the rebate agreement under this subsection, including terms and conditions related to compliance, that are consistent with this subsection. (8) Definitions In this subsection: (A) Applicable part B drug The term applicable part B drug means— (i) a drug or biological described in section 1842(o)(1)(C) for which payment is made under this section